Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LANSOPRAZOLE Cause Atrial fibrillation? 171 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Atrial fibrillation have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.3% of all adverse event reports for LANSOPRAZOLE.

171
Reports of Atrial fibrillation with LANSOPRAZOLE
0.3%
of all LANSOPRAZOLE reports
36
Deaths
67
Hospitalizations

How Dangerous Is Atrial fibrillation From LANSOPRAZOLE?

Of the 171 reports, 36 (21.1%) resulted in death, 67 (39.2%) required hospitalization, and 16 (9.4%) were considered life-threatening.

Is Atrial fibrillation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 171 reports have been filed with the FAERS database.

What Other Side Effects Does LANSOPRAZOLE Cause?

Chronic kidney disease (32,517) Acute kidney injury (16,359) Renal failure (12,509) End stage renal disease (9,734) Renal injury (9,383) Tubulointerstitial nephritis (3,860) Death (2,517) Gastrooesophageal reflux disease (2,482) Off label use (2,183) Nephrogenic anaemia (2,162)

What Other Drugs Cause Atrial fibrillation?

APIXABAN (5,690) IBRUTINIB (3,671) LENALIDOMIDE (2,704) RITUXIMAB (2,100) SACUBITRIL\VALSARTAN (2,062) RIVAROXABAN (2,027) ADALIMUMAB (1,709) METOPROLOL (1,462) DEXAMETHASONE (1,461) METHOTREXATE (1,411)

Which LANSOPRAZOLE Alternatives Have Lower Atrial fibrillation Risk?

LANSOPRAZOLE vs LANTHANUM LANSOPRAZOLE vs LANTUS LANSOPRAZOLE vs LANTUS SOLOSTAR LANSOPRAZOLE vs LAPATINIB LANSOPRAZOLE vs LAPATINIB DITOSYLATE

Related Pages

LANSOPRAZOLE Full Profile All Atrial fibrillation Reports All Drugs Causing Atrial fibrillation LANSOPRAZOLE Demographics